Chakravarthy Nachu Narasimhan
Inventor
Stats
- 2 US patents issued
- 14 US Applications filed
- most recent filing
This is official USPTO record data
Details
- 2 US Patents Issued
- 14 US Applications Filed
- 94 Total Citation Count
- Sep 11, 2024 Most Recent Filing
- Mar 29, 2012 Earliest Filing
Work History
| Patent Owner | Applications Filed | Year |
|---|---|---|
| MERCK SHARP & DOHME CORP. | 2
2 | 2012
2013 |
Inventor Addresses
| Address | Duration |
|---|---|
| Scotch Plains, NJ, US | Aug 21, 14 - Mar 06, 25 |
Technology Profile
| Technology | Matters | |
|---|---|---|
| A61K: | PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES | 14 |
| A61P: | THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS | 2 |
| C07K: | PEPTIDES | 10 |
Patents / Publication
| Patents / Publication # | Year of Publication / Issued | Title | Citations |
|---|---|---|---|
| 2025/0074,985 | 2025 | STABLE FORMULATIONS OF ANTI-CTLA4 ANTIBODIES ALONE AND IN COMBINATION WITH PROGRAMMED DEATH RECEPTOR 1 (PD-1) ANTIBODIES AND METHODS OF USE THEREOF | 0 |
| 2024/0182,573 | 2024 | STABLE FORMULATIONS OF ANTI-TIGIT ANTIBODIES ALONE AND IN COMBINATION WITH PROGRAMMED DEATH RECEPTOR 1 (PD-1) ANTIBODIES AND METHODS OF USE THEREOF | 0 |
| 2023/0321,234 | 2023 | STABLE FORMULATIONS OF PROGRAMMED DEATH RECEPTOR 1 (PD-1) ANTIBODIES AND METHODS OF USE THEREOF | 0 |
| 2023/0263,887 | 2023 | STABLE FORMULATIONS OF PROGRAMMED DEATH RECEPTOR 1 (PD-1) ANTIBODIES AND METHODS OF USE THEREOF | 0 |
| 2021/0380,694 | 2021 | STABLE FORMULATIONS OF PROGRAMMED DEATH RECEPTOR 1 (PD-1) ANTIBODIES AND METHODS OF USE THEREOF | 1 |
We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level.
>
Upgrade to our Level for up to -1 portfolios!.